Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/29/2026 | 20,394 | 0.1% | 26,421 | 12/31/2025 |
| 2025 Q3 | 11/5/2025 | 15,474 | 0.1% | 27,521 | 9/30/2025 |
| 2025 Q2 | 8/5/2025 | 14,816 | 0.1% | 28,221 | 6/30/2025 |
| 2025 Q1 | 4/30/2025 | 18,089 | 0.1% | 28,521 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 20,388 | 0.1% | 28,621 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 30,403 | 0.2% | 28,921 | 9/30/2024 |
| 2024 Q2 | 7/26/2024 | 30,502 | 0.2% | 29,021 | 6/30/2024 |
| 2024 Q1 | 4/18/2024 | 27,836 | 0.1% | 28,921 | 3/31/2024 |
| 2023 Q4 | 1/23/2024 | 25,752 | 0.2% | 29,321 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 24,686 | 0.2% | 29,997 | 9/30/2023 |
| 2023 Q2 | 7/26/2023 | 21,985 | 0.1% | 30,597 | 6/30/2023 |
| 2023 Q1 | 4/28/2023 | 25,387 | 0.2% | 30,897 | 3/31/2023 |
| 2022 Q4 | 1/27/2023 | 22,003 | 0.2% | 30,497 | 12/31/2022 |
| 2022 Q3 | 10/24/2022 | 21,697 | 0.2% | 31,497 | 9/30/2022 |
| 2022 Q2 | 8/8/2022 | 18,678 | 0.1% | 31,597 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 21,160 | 0.1% | 30,297 | 3/31/2022 |
| 2021 Q4 | 1/27/2022 | 18,925 | 0.1% | 29,968 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 16,517 | 0.1% | 27,292 | 9/30/2021 |
| 2021 Q2 | 7/27/2021 | 15,188 | 0.1% | 27,192 | 6/30/2021 |
| 2021 Q1 | 7/27/2021 | 12,866 | 0.1% | 27,192 | 3/31/2021 |
| 2020 Q4 | 7/27/2021 | 13,137 | 0.1% | 27,192 | 12/31/2020 |
| 2020 Q3 | 10/26/2020 | 15,333 | 0.1% | 27,392 | 9/30/2020 |
| 2020 Q2 | 7/29/2020 | 16,085 | 0.1% | 25,792 | 6/30/2020 |
| 2020 Q1 | 5/1/2020 | 8,957 | 0.1% | 18,344 | 3/31/2020 |
| 2019 Q4 | 1/24/2020 | 7,263 | 0.1% | 19,344 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 9,237 | 0.1% | 32,700 | 6/30/2014 |
| 2014 Q1 | 5/6/2014 | 9,639 | 0.1% | 32,100 | 3/31/2014 |
| 2013 Q4 | 2/7/2014 | 8,780 | 0.1% | 31,900 | 12/31/2013 |